UnknownPhase 1

Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma

Tunisia60 participantsStarted 2019-05-20

Plain-language summary

Our study is a prospective double-blind randomized study performed in the Emergency Department (ED). The objective of our study was to demonstrate the additive effect of high and repeated doses of inhaled budesonide combined with the standard treatment of acute asthma in adult managed in the ED

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * acute asthma * peak expiratory flow (PEF) rate less than 50% of predicted value * one or more of the following features were present: accessory muscle activity, a heart rate greater than 110 beats/minute, a respiratory rate greater than 25 breaths/minute, a limited ability to speak * written informed consent obtained Exclusion Criteria: * temperature higher than 38°C * history of cardiac, hepatic, renal, or other medical disease * pregnant

What they're measuring

admission rate

Timeframe: 3 hours

Trial details

NCT IDNCT04016220

SponsorUniversity of Monastir

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-12-20

Contact for this trial

Soudani Marghli, Professor

00 216 73 109 019 soudani.marghli@rns.tn

View on ClinicalTrials.gov More Acute Asthma trials